Tag: Respiratory
AstraZeneca India gets CDSCO approval for Palivizumab, a preventive therapy for...
In India, Respiratory Syncytial Virus is the most common cause of hospitalization in children <1 years old
Digital respiratory devices market worth to be US$ 900 Billion by...
The increased frequency of respiratory disorders has pushed for advancements in the production of breathing equipment
Zydus’s COVID-19 drug ‘Virafin’ gets DCGI nod
91.15% of patients treated with PegIFN were RT PCR negative by day 7. A single dose of the antiviral Virafin administered subcutaneously early on shows significant clinical and virological improvement in moderate COVID-19 adult patients.......................
Boehringer Ingelheim India to focus on partnerships in NCD management in...
The company has touched lives of around 17 lakh* patients across focus therapy areas, establishing model for stroke care across 23 states and 3 UTs......................
COVID-19 has revived academic interest in respiratory disorders: Dr Jitendra Singh
As per the Union Minister Dr Jitendra Singh, one of the conspicuous outcomes is that the pandemic has suddenly revived academic interest in respiratory disorders...............
Covid-19 patients with co-morbidities should get admitted to hospital, say Experts
Speaking at the 13th edition of the ‘Illness to Wellness’ series by ASSOCHAM, many top experts opined that Covid-19 patients with co-morbidities need to be hospitalized instead of home isolation....................
Roche Diagnostics India’s Elecsys IL-6 test to help identify high risk...
Interleukin 6 (IL-6) is an early indicator for acute inflammation; enables clinical decision-making on managing critically ill patients. This test can be performed on over 2300 cobas instruments that are available across 500 cities in India....................
COVID-19: Researchers at CSIR-IICB explore neuro-invasive potential of SARS-CoV-2
SERB supported study shows that the collapse of the respiratory center in the brain may cause the breakdown of COVID-19 patients..............
Childhood vaccines reduce antibiotic consumption in low & middle income nations
Researchers at CDDEP, Berkeley, and Imperial College London assessed the impact of PCVs and rotavirus vaccines on antibiotic consumption among children in low- and middle-income countries...................
Cipla EU & Jiangsu Acebright enter into a joint venture
According to the agreement, Cipla EU will hold an 80% stake and Acebright will hold a 20% stake in it for a combined investment of USD 30mn. Upon incorporation, the JV Co will set up a manufacturing facility for local manufacture of respiratory products.............